AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like BioSpace Partners With To Offer Cost Savings To Members July 11, 2017 Is There A Silver Lining For Fitbit? February 14, 2017 More R&D Fat is Trimmed as Biogen Closes Doors on UK's Convergence Pharma May 11, 2017
